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Summary. We contribute to the small, but important, literature exploring the incidence and
implications of misreporting in survey data. Specifically, when modelling ‘social bads’, such as
illegal drug consumption, researchers are often faced with exceptionally low reported partici-
pation rates. We propose a modelling framework where firstly an individual decides whether to
participate or not and, secondly, for participants there is a subsequent decision to misreport or
not.We explore misreporting in the context of the consumption of a system of drugs and specify
a multivariate inflated probit model. Compared with observed participation rates of 12.2%, 3.2%
and 1.3% (for use of marijuana, speed and cocaine respectively) the true participation rates
are estimated to be almost double for marijuana (23%), and more than double for speed (8%)
and cocaine (5%). The estimated chances that a user would misreport their participation is a
staggering 65% for a hard drug like cocaine, and still about 31% and 17%, for the softer drugs
of marijuana and speed.
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1. Introduction and background
Over the past three decades, the increased availability of microlevel data sets has enabled re-
searchers to explore an extensive range of research themes at the individual and household level.
Such microlevel data are invariably collected by using survey techniques with the result that the
quality of the data that are gathered hinges critically on the respondents providing reliable and
accurate information. It is apparent, however, that the subject matter of some surveys may be
such that respondents have an incentive to misreport because of the sensitive nature of the ques-
tions. Individuals may have an incentive to underreport activities which are regarded as socially
undesirable or which are associated with perceived social stigma or legal consequences, such
as smoking, alcohol, illicit drug consumption and sexual behaviours (e.g. Berg and Lien (2006)
and Pudney (2007)).
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Misreporting will result in inaccurate estimates of the prevalence of such behaviours, which
may lead us to question the validity of empirical conclusions that are drawn from surveys.
Moreover, any systematic misreporting will probably lead to biased inferences in econometric
analyses and erroneous policy advice. Despite these extremely important implications there is a
shortage of relevant research exploring the incidence and likely effects of such misreporting in
survey data.
Misclassification, or misreporting, often leads to the presence of ‘excess’ 0s, which has long
been of interest to the applied researcher. To address such concerns, hurdle and double-hurdle
models have been developed and have found favour in areas ranging from a continuous de-
pendent variable with a non-zero probability mass at (typically, but not exclusively) zero levels
(Cragg, 1971; Smith, 2003), to the so-called zero-inflated (augmented) Poisson count data mod-
els (Mullahey, 1986, 1997; Heilbron, 1989; Lambert, 1992; Greene, 1994; Pohlmeier andUlrich,
1995) and, more recently, to zero-inflated ordered probit models (Harris and Zhao, 2007). Typi-
cally, the issue that arises is that ‘0’-observations can result from two distinct processes and that
ignoring this can lead to seriously misspecified models.
In this paper, we explore the modelling of sensitive response variables: variables where an
associated loss function (perceived or actual) is involved for the individual in terms of the
responses that he or she reports. Here, it is clear that the researcher must be aware of the
potential for misreporting. For consumption of goods with associated reporting loss functions,
the approach that is suggested here allows for these 0-observations to correspond not only
to non-participants, but importantly also to those participants who erroneously report zero
consumption.
Our particular application lies in the important area of misreporting within the context of
the consumption of illicit drugs. Given the considerable individual and social costs that are
associated with the consumption of illegal drugs (including increased crime, health issues and
difficulties at school or work) it is not surprising that an extensive body of research exists
exploring issues that are related to the addictive nature of drugs as well as the relationship
between the consumption of different types of drug. However, as argued by MacDonald and
Pudney (2000) and Pudney (2010), there is no consensus regarding policy advice relating to drug
abuse and, furthermore, analysis of survey data relating to drug use could potentially contribute
to the policy debate in this area. The use of cross-sectional surveys to model socio-economic
determinants of drug use (Duarte et al., 2005; Ramful and Zhao, 2009) and panel surveys to
estimate rational addiction models (Becker et al., 1994; Labeaga, 1999) and demand elasticities
are therefore important tools of present-day policy making.
It is apparent that the shortcomings of this type of data should therefore be well understood
in order to make appropriate policy decisions. Indeed, in the context of survey response rates
and response accuracy, Pudney (2010), page 26, commented that
‘these problems cannot be overcome completely and their impact on research findings is not yet well
understood’.
Hence, we aim to contribute to the relatively small, but clearly important, literature exploring
the incidence and extent of misreporting (specifically with regard to drug consumption) in
individual level survey data.
Our approach is similar to that of Hausman et al. (1998) who used a logit model to estim-
ate misclassification probabilities. They considered a binary choice model with two types of
misclassification: the probability that the true 0 is recorded as a 1, and the probability that the
true 1 is recorded as a 0. Our specific contributions to the literature are threefold. Firstly, we
extend the general approach of Hausman et al. (1998) to allow for covariates to influence the
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misreporting, or misclassification, decision; this will be very important for policy makers to
help to identify those individuals with greater propensities to do so. Secondly, we acknowledge
that many ‘similar’ response variables of interest (various illicit drugs in our example) are likely
to be consumed jointly (here because of their common addictive nature), so we extend the
simpler univariate approach to a multivariate approach. Finally, we apply this newmodel to the
consumption of illegal drugs (in Australia) and thereby provide new evidence about the likely
extent ofmisreporting across these.Wealsoprovide evidence about the true rates of participation
across these drugs compared with a simple inspection of observed participation rates.
The rest of the paper is as follows. Section 2 describes the econometric setting; the empirical
application to a system of drug participation equations is described in Section 3. The data and
empirical results (including a series of robustness checks, validation exercises and Monte Carlo
experiments) are detailed in Sections 4 and 5 respectively. Finally, Section 6 concludes.
2. Econometric framework
2.1. An inflated probit model
We start by defining a discrete random variable y that is observable and assumes the binary
outcomes of 0 and 1. A standard probit approach would map a single latent variable to the
observed outcome y=1 via an index function, essentially modelling participation rates. In the
context of illegal drug use, we hypothesize that a (potentially significantly large) proportion of
participants will actually report themselves as being non-participants, because of both moral
and legal concerns about participation. Specifically, let rÅ denote a binary variable indicating the
split between regimes 0 (with r=0 for non-participants) and 1 (r=1 for participants). Although
unobservable, r is related to a latent variable rÅ via the mapping: r =1 for rÅ >0 and r =0 for
rÅ0. Thus rÅ represents the propensity for participation and is related to a set of explanatory
variables xr with unknown weights βr, and a standard normally distributed error term "r, such
that
rÅ = x′rβr + "r: .1/
For participants .r =1/, a second latent variable mÅ represents the propensity to misreport.
Again this is related to a second unobserved variable m such that m= 1 for mÅ > 0 and m= 0
for mÅ0, where m=0 represents a misreporter and m=1 a true reporter. Again, we can write
this (linear) latent form as
mÅ = x′mβm + "m: .2/
Of course, neither r nor m is observed; the observability criterion for observed y is
y = rm: .3/
As such the observed realization of the random variable y can be viewed as the result of two
independent latent equations, equations (1) and (2). However, these equations correspond to
the same individual so it is likely that the vector of stochastic terms εi will be related across
equations (which is a point that has been ignored in the previous literature). Allowing ."r, "m/
to follow a bivariate normal distribution with covariance matrix Ω (a 2× 2 symmetric matrix
with 1s on the diagonal and ρ on the off-diagonals) the relevant probabilities will have the form
Pr.y/=
{
Pr.y=0|x/=1−Φ.x′rβr/+Φ2.x′rβr, −x′mβm;Ω/,
Pr.y=1|x/=Φ2.x′rβr,x′mβm;Ω/ .4/
where Φ2 denotes the cumulative distribution function of the standardized bivariate normal
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distribution. The first term on the right-hand side of equation (4) for Pr.y = 0|x/ represents a
genuine non-participant; the second term, a (participant)misreporter. The expression for Pr.y=
1|x/ thus represents a (participant) true reporter. So here the probability of a 0-observation has
been ‘inflated’ as it is a combination of the probability of non-participation plus that from
misreporting. This approach thus models misreporting explicitly and as a function of a set of
explanatory variables unlike the model that was developed by Hausman et al. (1998) where
misreporting is accounted for by using constant terms, or by Dustmann and Soest (2001) who
decomposed misclassification errors in panel data into time persistent and time varying compo-
nents and where the probability of misclassification is independent of respondent characteris-
tics. However, it is very unlikely that such misreporting rates will be constant and homogeneous
across individuals. Moreover, ignoring this heterogeneity (if present) could lead to biased estim-
ates of quantities of interest (such as true participation rates). Owing to the 0-inflation and the
correlated disturbances, we term this a correlated inflated probit (IP) model. A test of ρ=0 is
jointly a test for independence of the two error terms and also one of the correlated IP versus
the nested IP model.
Given the assumed form for the probabilities and an independently and identically distributed
sample of size N from the population on .yi,x/, i=1, : : : ,N, the parameters of the full model
θ= .β′r,β′m,ρ/′ =β′ can be consistently and efficiently estimated by using maximum likelihood
techniques; the log-likelihood function is (where hij is the usual indicator function for the
observed choice)
l .θ/=
N∑
i=1
∑
j
hij ln {Pr.yi = j|x,θ/}: .5/
2.2. Extending to a multivariate inflated probit system
Often social bads such as licit and illicit drugs are consumed in a consumption bundle (see, for
example, Collins et al. (1998) and Ives and Ghelani (2006)), given that they are habit forming.
Instead of modelling the consumption of such social bads in isolation, the above set-up can be
extended to a multivariate framework where participation decisions are considered to be taken
jointly (see, for example, Zhao and Harris (2004) and Ramful and Zhao (2009)). Owing to
unobservable characteristics (such as individual tastes, addictive traits and risk-taking attitudes)
the decision to consume multiple drugs is very likely to be related through the error terms of
the participation and misreporting equations, i.e. via the unobservables. As a consequence,
vital cross-drug information is lost when the correlated IP model is estimated in a univariate
framework for several drugs of interest. As detailed below, we consider a system of three drugs.
The multivariate approach essentially isolates the joint effects of observable and unobservable
personal characteristics on the participation and misreporting of all three drugs and estimates
the strength of the intrinsic correlations, via the unobservables, across the three drugs which are
commonly considered to be closely related economic goods.
For a set of k .k=1, : : : ,K/multivariate correlated IPmodels, the propensity for participation
will be
rÅk =x′rkβrk + "rk .k =1, : : : ,K/, .6/
and the propensity to misreport will be
mÅk =x′mkβmk + "mk .k =1, : : : ,K/: .7/
There is no necessary restriction that xrk =xrh or that xmk =xmh,∀ k =h, but we shall assume so,
both in the empirical application and also below, to simplify the notation (i.e. the same covariate
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specification applies to all drugs). Economic and mathematical identification here, though, will
require that xrk =xmk,∀ k: for each drug equation we require exclusion restrictions with regard
to the participation and misreporting equations (but these are not necessary across the different
drug equations). The most general specification is to assume that the "rks and the "mks are freely
correlated both within and across equations. This results in s= 2K latent equations where the
error terms jointly follow a multivariate normal distribution of order s with covariance matrix
Σ given by
Σs =
⎛
⎜⎜⎜⎜⎜⎜⎝
1
ρr1m1 1
ρr1r2 ρm1r2 1
:::
:::
:::
: : :
ρr1rK ρm1rK ρr2rK : : : 1
ρr1mK ρm1mK ρr2mK : : : ρrKmK 1
⎞
⎟⎟⎟⎟⎟⎟⎠
, .8/
where ρr1m1 =ρm1r1 and so on (Σs is symmetric).
Consider a system of correlated IP models for three illicit drugs. Since K = 3, we have six
latent equations where, for example, ρr1m1 relates to the correlation between "r1 and "m1 , the
respective error terms from the participation equation and themisreporting equation relating to
the first drug. This results in a range of joint probabilities of interest, such as the polar cases of
Pr.y1 =1,y2 =1, y3 =1|x/=Φ6.x′r1βr1 ,x′m1βm1 ,x′r2βr2 ,x′m2βm2 ,x′r3βr3 ,x′m3βm3 ;Σ6/ .9/
and
Pr.y1=0,y2 =0,y3 =0|x/=Φ3.−x′r1βr1 , −x′r2βr2 , −x′r3βr3 ;Σ3/+Φ4.x′r1βr1 , −x′m1βm1 ,
−x′r2βr2 , −x′r3βr3 ;Σ4/+Φ4.−x′r1βr1 ,x′r2βr2 , −x′m2βm2 ,
−x′r3βr3 ;Σ4/+Φ4.−x′r1βr1 , −x′r2βr2 ,x′r3βr3 , −x′m3βm3 ;Σ4/
+Φ5.x′r1βr1 , −x′m1βm1 ,x′r2βr2 , −x′m2βm2 , −x′r3βr3 ;Σ5/
+Φ5.x′r1βr1 , −x′m1βm1 , −x′r2βr2 ,x′r3βr3 , −x′m3βm3 ;Σ5/
+Φ5.−x′r1βr1 ,x′r2βr2 , −x′m2βm2 ,x′r3βr3 , −x′m3βm3 ;Σ5/
+Φ6.x′r1βr1 , −x′m1βm1 ,x′r2βr2 , −x′m2βm2 ,x′r3βr3 , −x′m3βm3 ;Σ6/,
.10/
and also intermediate cases such as
Pr.y1 =1,y2 =0,y3 =0|x/=Φ4.x′r1βr1 ,x′m1βm1 , −x′r2βr2 , −x′r3βr3 ;Σ4/
+Φ5.x′r1βr1 ,x′m1βm1 ,x′r2βr2 , −x′m2βm2 , −x′r3βr3 ;Σ5/
+Φ5.x′r1βr1 ,x′m1βm1 , −x′r2βr2 ,x′r3βr3 , −x′m3βm3 ;Σ5/
+Φ6.x′r1βr1 ,x′m1βm1 ,x′r2βr2 , −x′m2βm2 ,x′r3βr3 , −x′m3βm3 ;Σ6/,
.11/
where Φn denotes the n-dimensional multivariate normal cumulative distribution function.
It is intuitive to take a closer look at these probabilistic expressions. Take, for example,
equation (9), which corresponds to the probability of observing participation in all three drugs.
Here all the six elements in parentheses on the right-hand side relate to participation and true
reporting in all of the three respective drugs. However, Pr.y1 =0, y2 =0, y3 =0|x/, or equation
(10), has a more complex form. This probability corresponds to an observed 0 in each of the
three drugs. This can occur in eight distinct ways; the individual can be
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(a) a true non-participant in each drug, first term,
(b) a misreporting participant in drug 1, with the relevant (upper) integration limits being
x′r1βr1 and −x′m1βm1 , but a true non-participant in drugs 2 and 3 .−x′r2βr2 , − x′r3βr3/,
second term,
:::
(h) a misreporting participant in all drugs, eighth term.
Σj defines the relevant submatrices of Σ with appropriate signs in the correlations. For ex-
ample, the relevant lower submatrix of Σ4 in the second right-hand side term of equation (10)
is defined as
Σ4 =
⎛
⎜⎝
1
−ρr1m1 1
−ρr1r2 ρm1r2 1
−ρr1r3 ρm1r3 ρr2r3 1
⎞
⎟⎠:
This multivariate IP (MIP) model can be estimated by maximum likelihood but, as the prob-
abilities entering this are functions of high dimensional multivariate normal distributions, these
are simulated by using the Geweke–Hajivassiliou–Keane algorithm (see, for example, Keane
(1994)) and Halton sequences (Train, 2000; Bhat, 2003) of length 500. In addition, since the
joint and conditional probabilities are highly non-linear functions of x, partial effects are calcu-
lated by using numerical gradients, and standard errors of these obtained by the delta method.
3. Application to drug consumption
Empirical studies play a crucial role in identifying the socio-economic and demographic factors
that are associated with the consumption of illicit drugs, providing invaluable information to
facilitate well-targeted public health policies. One strand of the existing literature in this area
focuses on exploring the determinants of the decision to take illegal drugs. However, one of the
key issues in the empirical literature on drug addiction and the demand for illicit drugs relates
to the accuracy of self-reported data and the incentive to misreport and underreport illicit drug
use. The extent of suchmisreporting and underreporting is likely to be influenced by a variety of
factors such as gender and ethnicity (see, for example,Mensch andKandel (1988) and Fendrich
and Vaughn (1994)).
Misreportingofdrugsusemayalsobe influencedbyhowthe survey is conducted. Inparticular,
the drop-and-collect and/or mail-back methods have been associated with lower underreport-
ing of sensitive information (Bowling, 2005). Presumably, this is due to the greater anonymity,
more privacy and confidentiality of themethod.For instance, comparing themail surveymethod
with computer-assisted telephone interviews (CATIs), Kraus and Augustin (2001) found that
a lower number of respondents would admit alcohol consumption if questioned by telephone
compared with self-reports from questionnaires. In a similar vein, Hoyt and Chaloupka (1994)
and Fendrich and Vaughn (1994) found that lower reported drugs use is associated with tele-
phone interviews. The increased use of CATIs in the gathering of information has arguably
improved the accuracy of such data although it is not clear to what extent the accuracy has been
improved (Morrison-Beedy et al., 2006).
In addition, given the apparent complex interrelationships between the demand for different
types of illicit drugs, it is apparent that the extent of misreporting may vary across different
types of drugs, arguably being particularly serious in the case of harder drugs (such as heroin
and cocaine). Pudney (2007) analysed the consequences of misreporting of illicit drugs use for
statistical inference by using UK panel data containing repeated questions on self-reported
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lifetime drug use. The findings indicate serious underreporting of the use of marijuana and
cocaine, which in turn leads to biases in statistical modelling. For example, for one of the data
sets that were analysed, underreporting rates for marijuana and cocaine with bounds averaging
respectively from 23% to 60% and from 31% to 95% for all individuals were observed.
Such findings are supported by the evidence from surveys which check self-reported data via
drug tests (usually for prisoners or arrestees), which indicate serious misreporting problems in
the case of hard drugs (see, for example, MacDonald and Pudney (2003)). For example, in an
early contribution, Wish (1987) analysed a sample of men arrested in New York City in 1984.
For cocaine, the interview data indicated a drug use rate of 43% compared with 82% elicited
from urine specimens. More recently, Lu et al. (2001) compared underreporting of drugs by
validating information obtained via interviews with urinalysis for a sample of adult arrestees.
The findings indicate significant levels of underreporting for all drugs with accurate reporting
declining from 64% in the case of marijuana to 46% in the case of opium.
However, the extent to which findings from such studies where cross-validation is possible can
be generalized is not apparent and is arguably limited given that suchdata are basedon somewhat
atypical circumstances and samples. Themodelling strategy that is outlined in this study, in con-
trast, requires only a single source of (cross-section) survey data without recourse to validation
from other sources, such as drug tests or historical information on lifetime drug consumption.
4. The data
The data that we use for the model are drawn from the Australian National Drug Strategy
Household Survey, which is a nationally representative survey of the Australian civilian popula-
tion aged over 14 years (National Drug Strategy Household Survey, 2010). The earlier waves of
the survey used face-to-face and drop-and-collect methods to collect data. The CATI method
of data collection was introduced in the 2001 survey and all three methods were employed to
collect data. The 2004 and 2007 surveys, in contrast, were administered by using only drop and
collect and CATIs, whereas the more recent surveys have been conducted using only the CATI
method. Note that our data set consists of independent cross-sectional surveys over time. The
key question is ‘have you used marijuana or cannabis (cocaine, speed) in the last 12 months?’.
Owing to consistencywith respect to the key variables of interest and the change in the collection
method in more recent years, we use data from the 2001, 2004 and 2007 surveys in this study. A
sample of 56579 individuals is thus available for estimation. These data have been used in several
previous studies (e.g. Harris and Zhao (2007), Van Ours and Williams (2011) and Williams and
Bretteville-Jensen (2014)).
In terms of explanatory variables, we require two sets: one to determine participation and
the other misreporting. Although many of these variables overlap, to facilitate identification we
ensure that xm have exclusion restrictions. In terms of common variables, in line with several
past studies on drug consumption (e.g. Gill and Michaels (1991), Saffer and Chaloupka (1999)
and Cameron and Williams (2001)), we include a wide range of personal and demographic
characteristics (such as gender, marital status, educational attainment, whether the individual
lives in a state where possession of small amounts of marijuana is decriminalized and income;
see the on-line appendix and Table 1). Inclusion of year and state dummies in both equations
allows for the fact that both participation and misreporting rates may follow different trends
over time, while also allowing for any difference in drug prices and policies across states.
We include a range of identifying variables in the misreporting equation: variables that (os-
tensibly) affect the misreporting decision(s) but not the participation decision(s). These identi-
fying variables in xm (to capture misreporting) mostly relate to the conditions under which the
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survey was administered, which, as discussed above, may potentially influence the extent to
which individuals misreport but will arguably be independent from any participation propen-
sities. Specifically, we control for whether anyone else was present when the respondent was
completing the survey questionnaire, whether anyone helped the respondent to complete the
survey questionnaire and whether the drop-and-collect survey mode was used. These variables
conform with the factors that have been associated with misreporting or misclassification in
prior studies (e.g. Mensch and Kandel (1988), O’Muircheartaigh and Campanelli (1998), Lu
et al. (2001), Kraus and Augustin (2001) and Berg and Lien (2006)).
Finally, we also include as an instrument a variable indicating a general lack of trust in
the survey which we measure by using the percentage of unanswered questions. This is based
on the significant amount of literature suggesting that the longer a respondent spends with
the interviewer the more trusting they are of both him or her and the survey in general (e.g.
Corbin and Morse (2003)). For each respondent it is possible to calculate the total number of
compulsory (asked to everyone) questions that are left unanswered (as a percentage); this is
clearly both a strong proxy for the length of time spent completing the survey, and as such an
indirect proxy for trust, and also (arguably) a direct measure of trust. Table 1 presents summary
Table 1. Summary statistics, sample size 56579
Variable Mean Standard Minimum Maximum
deviation
Ymar 0.1215 0.3267 0 1
Yspd 0.0316 0.175 0 1
Ycoc 0.0127 0.1118 0 1
MALE 0.4662 0.4989 0 1
STAGE −0:0238 0.9352 −1:7157 2.9028
STAGESQ −0:0460 0.9349 −1:2437 4.1373
MARRIED 0.5931 0.4913 0 1
PRESCHOOL 0.1232 0.3287 0 1
SINGPAR 0.0704 0.2558 0 1
CAPITAL 0.6437 0.4789 0 1
ATSI 0.0133 0.1144 0 1
WORK 0.6239 0.4844 0 1
STUDY 0.0619 0.2409 0 1
UNEMP 0.0225 0.1482 0 1
DEGREE 0.2626 0.4400 0 1
YR12 0.1295 0.3358 0 1
DIPLOMA 0.3488 0.4766 0 1
LRPINC 9.7776 0.9324 6.6400 11.2708
DECRIM 0.2534 0.4350 0 1
MIGR10 0.0435 0.2040 0 1
YR04 0.3593 0.4798 0 1
YR07 0.2887 0.4532 0 1
VIC 0.2053 0.4039 0 1
QLD 0.1794 0.3837 0 1
WA 0.1107 0.3137 0 1
SA 0.0840 0.2775 0 1
TAS 0.0474 0.2126 0 1
ACT 0.0538 0.2257 0 1
NT 0.0478 0.2134 0 1
PRESENT 0.2916 0.4545 0 1
HELP 0.2144 0.4104 0 1
SURVTYPE 0.1671 0.3730 0 1
TRUST 0.0397 0.0615 0 0.6688
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statistics relating to the variables that were used in our econometric analysis for the pooled
cross-section data set. The variables are fully described in the on-line appendix.
5. Results
5.1. Estimated parameters
In estimating the joint MIP model (with 15 correlation coefficients) we note that the estimated
coefficients and their statistical significance do not change dramatically from the univariate cor-
related IP results. Although the differences in the estimated parameters from the more complex
MIP model are quite negligible, the main advantage of estimating the system model is that it
allows us to estimate a whole range of joint and conditional probabilities of interest (see below).
In Table 2 we present the MIP estimated coefficients for the participation and misreporting
equations and, in Table 3, the correlation coefficients. In general, the system model does a very
good job, in terms of statistical significance, of modelling such difficult data with such low
observed (recorded) participation rates. Before briefly describing some main findings, Table 3
shows that there are several significant correlations both across and within drugs (and the full
set is jointly significant), suggesting the existence of complex interrelationships in the participa-
tion and reporting decisions here, and that both observed and unobserved heterogeneity play a
significant role.
With regard toparticipation,wefind that gender andmarital status are significantly associated
with all three drugs. Age has a statistically significant effect on the participation probabilities of
marijuana and speed. In line with previous literature (see, for example, Farrelly et al. (2001) and
Saffer and Chaloupka (1998)), decriminalization is negatively associated with participating in
marijuana consumption. Income is negatively associated with marijuana consumption, which
may be a reflection of social class. The relationship between education and illicit drug consump-
tion appears to be somewhat complex with the effect varying significantly across the three drugs:
educationhasno significant effect on cocaineuse; in the caseofmarijuana, higher levels of educa-
tion are associatedwith a higher probability of participation, whereas, for speed, themore highly
educated is the individual, the lower is their probability of participating. Suchfindingsmay reflect
the different social norms, recreational activities and/or preferences across educational groups.
Turning to the misreporting equations, and noting that a positive coefficient indicates a lower
probability of misreporting, we see that being male is associated with a higher probability of
misreporting speed but with lower chances of misreporting marijuana consumption. Age has
no significant effect on the probability of misreporting marijuana but we find a quadratic effect
of age on the probability of misreporting speed and cocaine. Interestingly, income is positively
associated with accurately reporting all three drugs. As expected, the more educated individuals
have a higher probability of misreporting marijuana and speed but education does not seem
to affect reporting behaviour of cocaine. The introduction of decriminalization is likely to be
associated with increased awareness of the potential consequences that are associated with
consuming illicit drugs, through increased debate as well as campaigns (such as the Australian
National Campaign Against Drug Abuse). Surprisingly, we do not find evidence of any effect
of decriminalization on the probability of misreporting marijuana or any of the other drugs. We
find an increasing trend in misreporting behaviour across the years, reflecting a changing trend
in opinions with regard to drug use.
The identification of our model hinges, to a large extent, on the exclusion strategy that is
employed. With respect to the effects of the identifying set of variables in the misreporting
equation, the presence of anyone else when the respondent was completing the questionnaire is
associated with a higher probability of misreporting across all three drugs, consistent with Hoyt
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Table 2. Marijuana, speed and cocaine consumption: estimated coefficients†
Variable Results for marijuana Results for speed Results for cocaine
Participation Misreporting Participation Misreporting Participation Misreporting
CONSTANT 0.243 −0:763 −2:347 0.435 −2:339 −6:020
(0.286) (0.384)§ (0.336)‡ (1.446) (1.066)§ (1.574)‡
MALE 0.409 0.148 0.381 −0:206 0.192 0.054
(0.029)‡ (0.049)‡ (0.045)‡ (0.118)§§ (0.071)‡ (0.153)
STAGE −1:010 0.445 −2:211 3.880 −1:131 5.039
(0.183)‡ (0.311) (0.387)‡ (0.925)‡ (1.045) (1.483)‡
STAGESQ −0:218 −0:022 1.099 −3:197 0.566 −7:383
(0.167) (0.540) (0.430)§ (1.579)§ (1.478) (1.987)‡
MARRIED −0:523 −0:053 −0:521 0.410 −0:594 0.545
(0.034)‡ (0.082) (0.048)‡ (0.210)§§ (0.111)‡ (0.381)
PRESCHOOL −0:041 −0:256 −0:320 0.251 −0:247 0.152
(0.053) (0.075)‡ (0.060)‡ (0.198) (0.105)§ (0.347)
SINGPAR 0.035 0.055 0.078 −0:050 −0:098 −0:106
(0.048) (0.061) (0.062) (0.105) (0.156) (0.274)
CAPITAL −0:067 0.109 0.135 0.123 0.312 0.211
(0.031)§ (0.044)§ (0.042)‡ (0.085) (0.102)‡ (0.227)
ATSI 0.004 0.196 0.025 −0:367 −0:582 1.200
(0.106) (0.143) (0.145) (0.227) (0.326)§§ (0.910)
WORK 0.083 −0:339 −0:111 −0:270 0.034 0.014
(0.052) (0.095)‡ (0.069) (0.180) (0.164) (0.359)
STUDY 0.518 −0:432 0.319 −0:644 0.541 −0:275
(0.132)‡ (0.110)‡ (0.146)§ (0.205)‡ (0.252)§ (0.441)
UNEMP 0.135 0.309 0.038 0.259 0.172 −0:083
(0.078)§§ (0.143)§ (0.103) (0.241) (0.248) (0.458)
DEGREE 0.181 −0:444 −0:367 −0:344 −0:011 0.044
(0.052)‡ (0.076)‡ (0.063)‡ (0.148)§ (0.136) (0.261)
YR12 0.034 −0:158 −0:202 −0:091 0.020 0.034
(0.046) (0.059)‡ (0.065)‡ (0.103) (0.145) (0.249)
DIPLOMA 0.066 −0:089 −0:149 0.006 −0:103 0.359
(0.036)§§ (0.059) (0.050)‡ (0.103) (0.135) (0.266)
LRPINC −0:160 0.195 0.029 0.159 0.033 0.427
(0.028)‡ (0.032)‡ (0.035) (0.057)‡ (0.077) (0.116)‡
DECRIM −0:253 0.165 0.026 −0:048 −0:223 0.508
(0.082)‡ (0.110) (0.105) (0.185) (0.213) (0.423)
MIGR10 0.082 −0:415 0.103 −0:897 0.205 −0:419
(0.097) (0.089)‡ (0.124) (0.187)‡ (0.149) (0.246)§§
YR04 0.117 −0:213 0.121 −0:207 0.179 −0:623
(0.035)‡ (0.053)‡ (0.046)‡ (0.094)§ (0.103)§§ (0.246)§
YR07 0.238 −0:539 0.210 −0:917 0.450 −0:638
(0.053)‡ (0.067)‡ (0.073)‡ (0.142)‡ (0.108)‡ (0.306)§
VIC −0:143 0.117 −0:101 −0:177 −0:306 0.207
(0.041)‡ (0.059)§ (0.058)§§ (0.107)§§ (0.098)‡ (0.232)
QLD −0:136 0.120 −0:107 −0:175 −0:529 0.382
(0.043)‡ (0.060)§ (0.059)§§ (0.111) (0.133)‡ (0.343)
WA 0.260 0.062 0.140 0.199 −0:113 −0:279
(0.066)‡ (0.085) (0.085) (0.147) (0.156) (0.290)
SA 0.294 −0:066 0.024 0.125 −0:153 −0:581
(0.098)‡ (0.135) (0.127) (0.226) (0.266) (0.499)
TAS −0:022 0.121 −0:239 −0:367 −0:621 −0:187
(0.065) (0.098) (0.111)§ (0.208)§§ (0.307)§ (0.661)
ACT 0.093 −0:022 −0:166 0.139 −0:261 −0:346
(0.102) (0.143) (0.146) (0.271) (0.256) (0.535)
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Table 2 (continued )
Variable Results for marijuana Results for speed Results for cocaine
Participation Misreporting Participation Misreporting Participation Misreporting
NT 0.715 −0:200 0.295 −0:701 −0:389 −0:211
(0.109)‡ (0.156) (0.139)§ (0.250)‡ (0.268) (0.596)
PRESENT −0:192 −0:404 −0:364
(0.039)‡ (0.088)‡ (0.155)§
HELP −0:051 0.024 0.118
(0.048) (0.099) (0.172)
SURVTYPE −0:212 −0:288 −0:664
(0.058)‡ (0.111)‡ (0.256)‡
TRUST −1:435 −1:753 −3:518
(0.347)‡ (0.761)§ (1.348)‡
†Standard errors are given in parentheses. A positive coefficient for participation indicates an increase in the
probability of participation whereas a negative coefficient for misreporting indicates an increase in the probability
of misreporting.
‡Significant at the 1% level.
§Significant at the 5% level.
§§Significant at the 10% level.
Table 3. Correlation coefficients†
Mmar Rmar Mspd Rspd Mcoc Rcoc
Mmar —
Rmar 0.069 —
(0.135)
Mspd 0.504 0.199 —
(0.066)‡ (0.235)
Rspd 0.205 0.601 0.078 —
(0.094)§ (0.040)‡ (0.372)
Mcoc 0.300 0.299 0.025 0.028 —
(0.107)‡ (0.265) (0.122) (0.128)
Rcoc 0.101 0.498 0.037 0.031 0.080 —
(0.096) (0.076)‡ (0.118) (0.043) (0.426)
†Standard errors are given in parentheses.
‡Significant at the 1% level.
§Significant at the 5% level.
and Chaloupka (1994). Seeking help from someone to complete the questionnaire does not
appear to have a significant effect on reporting participation in any of the drugs. Clearly, survey
type, i.e. the CATI method or face-to-face interview (relative to drop and collect), is associated
with a higher probability of misreporting across all three drugs. Finally, if the respondent had
a general lack of trust in the survey then they have a higher chance of misreporting drug use.
In summary, since three of the four identifying variables exhibit high levels of significance and
in the expected direction, we are confident in our identification strategy and, consequently, our
results overall.
5.2. Predicted probabilities and partial effects
There are numerous probabilities that one may be interested in in predicting with the current
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Table 4. Sample and predicted probabilities†
Results for Results for Results for
marijuana speed cocaine
Sample rate of participation 0.1215 0.0316 0.0127
Marginal probability of participation, Pr.r =1|x/ 0.2326 0.0838 0.0486
(0.0178)‡ (0.0112)‡ (0.0224)‡
Joint probability of participation and 0.1206 0.0281 0.0137
accurate reporting, Pr.r =1,m=1|x/ (0.0013)‡ (0.0007)‡ (0.0007)‡
Probability of misreporting conditional 0.3064 0.1702 0.6467
on participation Pr.m=0|r =1,x/ (0.0683)‡ (0.0698)‡ (0.1236)‡
Components of the 0s
Non-participation, Pr.r =0|x/ 0.7674 0.9162 0.9514
(0.0178)‡ (0.0112)‡ (0.0224)‡
Misreporting, Pr.r =1,m=0|x/ 0.1120 0.0558 0.0349
(0.0178)‡ (0.0111)‡ (0.0224)
Total 0.8794 0.9719 0.9863
(0.0013)‡ (0.0007)‡ (0.0007)‡
Posterior probabilities
Non-participation, Pr.r =0|x,y=0/ 0.8692 0.9509 0.9690
(0.0204)‡ (0.0098)‡ (0.0204)‡
Misreporting, Pr.r =1,m=0|x,y=0/ 0.1308 0.0491 0.0310
(0.0204)‡ (0.0098)‡ (0.0204)
†Standard errors are given in parentheses.
‡Significant at the 1% level.
model. For each drug in isolation, one may be interested in the marginal probability of partic-
ipation, the joint probability of participation and misreporting or the probability of accurate
reporting, conditionally on participation. In Table 4 we present some summary probabilities
that are associated with each of the drugs (evaluated individually and then averaged over the
sample). As expected, across all three drugs, the predicted marginal probabilities of partici-
pation are higher than the sample rates of participation as indicated by the survey responses.
Specifically, on the basis of the survey responses, one would estimate participation rates in mar-
ijuana, speed and cocaine respectively to be 12.2%, 3.2% and 1.3%. However, we estimate, once
misreporting has been taken into account, that these are significantly higher at 23.3%, 8.4%
and 4.9% respectively. Given the small standard errors of these, they also appear to be quite
precisely estimated. The joint probability of participation and accurate reporting (alternatively,
the recorded probability of participation, Pr.y=1|x/) allows us to assess the performance of our
model as they are directly comparable with the sample proportions. We find that for all three
drugs the joint probabilities mimic the observed sample proportions very closely.
Conditionally on an individual participating, there was a 65% chance of misreporting
cocaine use compared with 31% for marijuana, i.e. of the small percentage of cocaine users
in the population (recorded at 1.3% and estimated at just under 5%) 65% claimed not to be.
This may appear high, but it is in line with previous studies (Pudney, 2007). This difference
between cocaine and marijuana may reflect the greater risk that is associated with the former.
For speed the estimated conditional probability of misreporting was 17%, which is significantly
less than for the other two drugs. This lower misreporting rate may be related to the younger age
and lower education of speed consumers, a demographic for which speed consumption may be
consideredmore ‘socially acceptable’. Overall, these findings suggest thatmisreporting in survey
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data may lead to considerable underestimation of participation rates in the case of consumption
of illicit drugs, especially with regard to both marijuana and cocaine in the current study.
Togainmore insights into the sourceof theobserved0s,wealsopresent inTable 4 thepredicted
probability of 0s for each of the three drugs broken down into two respective components: non-
participation and misreporting. For example, the overall predicted probability of 87.9% of
zero consumption in the case of marijuana is made up of the respective probability of non-
participation (76.7%) and misreporting (11.2%). In view of the low rates of participation, the
low misreporting components here (of 11.2%, 5.6% and 3.5%) may appear to be quite small.
However, when translated to the Australian population aged 14 years and above, they represent
nearly 2016000, 1004000 and 629000 cases of unreported cases ofmarijuana, speed and cocaine
use respectively. Such underreporting can thus have extremely important implications for drug
policies.
Such probabilities can be thought of as prior probabilities, i.e. they apply to a randomly se-
lected individual from the population, aboutwhomweknownothing except their characteristics.
However, to provide further insights into the extent of misreporting, it is possible to estimate
posterior probabilities, analogously to those considered in latent class models (Greene, 2012),
that are conditional on knowing what outcome the individual chose. Specifically, this allows us
to make a prediction on what percentage of these 0s comes from non-participation and misre-
porting respectively, using all the information that we have on the individual: this attempts to
answer the question ‘given that an individual recorded a 0, what is the probability that they are
a true non-participant versus a misreporting participant (given their observed characteristics)?’.
The posterior probabilities for the two types of 0s are given as
Pr.r =0|x, y=0/=f.r =0|x/
f.y=0/
= 1−Φ.x
′
rβr/
1−Φ.x′rβr/+Φ2.x′rβr, −x′mβm, −ρrm/
.12/
and
Pr.r =1,m=0|x, y=0/=f.r =1,m=0|x/
f.y=0/
= Φ2.x
′
rβr, −x′mβm, −ρrm/
1−Φ.x′rβr/+Φ2.x′rβr, −x′mβm, −ρrm/
: .13/
From Table 4, we find that close to 87% of the reported 0s for marijuana are estimated to
come fromgenuine non-participation (and therefore 13% frommisreported participation).Note
that, as with the prior probabilities that were presented earlier, these posterior probabilities for
misreporting might appear, superficially, rather low. However, it is important to remember that
the probabilities for misreporting here are not marginal, but joint of participation and misre-
porting. Thus, given that participation probabilities are very low for all these drugs (estimated
at about 23%, 8% and 5% respectively for marijuana, speed and cocaine; see the second row of
Table 4), it is not surprising that these joint probabilities are also small. Moreover, as with all
the predicted probabilities, estimated standard errors are generally (relatively) very small, giving
us greater confidence in their magnitudes.
Considering the full system of demand equations, as in the current approach, one may also
be interested in any of numerous cross-drug probabilities such as the joint probability of par-
ticipating in marijuana, speed and cocaine and the conditional probability of misreporting co-
caine conditionally on marijuana participation. Indeed, it is not immediately obvious how one
would undertake such an exercise if these drug equations were estimated separately. We can also
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Table 5. Partial effects on selected joint and conditional probabilities†
Variable Pr(ymar =0,yspd =0,ycoc =0|x) Pr(yspd =0,ycoc =0|rmar =1,x)
Participation Misreporting Overall Participation Misreporting Overall
MALE −0:053 −0:006 −0:059 −0:030 0.047 0.017
(0.009)‡ (0.003)§§ (0.007)‡ (0.015)§ (0.021)§ (0.021)
STAGE 0.143 −0:028 0.115 0.238 0.070 0.308
(0.036)‡ (0.022) (0.045)§ (0.074)‡ (0.112) (0.107)‡
STAGESQ 0.016 0.010 0.026 −0:151 0.086 −0:065
(0.021) (0.024) (0.033) (0.068)§ (0.189) (0.174)
MARRIED 0.067 0.002 0.069 0.048 −0:024 0.023
(0.013)‡ (0.004) (0.010)‡ (0.020)§ (0.027) (0.026)
PRESCHOOL 0.008 0.011 0.019 0.040 −0:084 −0:044
(0.007) (0.005)§ (0.005)‡ (0.010)‡ (0.027)‡ (0.030)
SINGPAR −0:005 −0:002 −0:008 −0:007 0.019 0.012
(0.007) (0.003) (0.005) (0.008) (0.020) (0.020)
CAPITAL 0.007 −0:005 0.002 −0:024 0.032 0.008
(0.004)§§ (0.002)§ (0.003) (0.008)‡ (0.015)§ (0.017)
ATSI −0:002 −0:009 −0:012 0.005 0.051 0.056
(0.016) (0.012) (0.014) (0.025) (0.058) (0.065)
WORK −0:009 0.015 0.007 0.017 −0:106 −0:089
(0.006) (0.005)‡ (0.005) (0.009)§§ (0.034)‡ (0.035)§
STUDY −0:064 0.020 −0:044 −0:023 −0:131 −0:153
(0.017)‡ (0.007)‡ (0.017)‡ (0.024) (0.040)‡ (0.038)‡
UNEMP −0:016 −0:014 −0:030 −0:001 0.097 0.097
(0.013) (0.009) (0.009)‡ (0.020) (0.050)§§ (0.052)§§
DEGREE −0:018 0.020 0.002 0.053 −0:140 −0:087
(0.007)‡ (0.006)‡ (0.006) (0.013)‡ (0.032)‡ (0.038)§
YR12 −0:002 0.007 0.005 0.026 −0:050 −0:024
(0.006) (0.003)§ (0.005) (0.009)‡ (0.019)‡ (0.021)
DIPLOMA −0:007 0.004 −0:003 0.022 −0:032 −0:009
(0.005) (0.003) (0.004) (0.008)‡ (0.019)§§ (0.020)
LRPINC 0.019 −0:009 0.010 −0:011 0.056 0.045
(0.004)‡ (0.002)‡ (0.004)§ (0.007) (0.013)‡ (0.015)‡
DECRIM 0.030 −0:008 0.022 −0:012 0.047 0.035
(0.011)‡ (0.005) (0.010)§ (0.016) (0.035) (0.036)
MIGR10 −0:011 0.020 0.009 −0:012 −0:123 −0:134
(0.012) (0.008)§ (0.010) (0.017) (0.034)‡ (0.036)‡
YR04 −0:015 0.010 −0:005 −0:012 −0:060 −0:071
(0.005)‡ (0.003)‡ (0.005) (0.007) (0.019)‡ (0.019)‡
YR07 −0:030 0.025 −0:004 −0:021 −0:160 −0:180
(0.007)‡ (0.006)‡ (0.009) (0.013) (0.035)‡ (0.031)‡
VIC 0.017 −0:005 0.012 0.010 0.035 0.045
(0.006)‡ (0.003)§§ (0.005)§ (0.009) (0.020)§§ (0.019)§
QLD 0.016 −0:005 0.011 0.014 0.035 0.049
(0.006)§ (0.003)§§ (0.006)§§ (0.009) (0.020)§§ (0.020)§
WA −0:033 −0:003 −0:036 −0:004 0.022 0.018
(0.009)‡ (0.004) (0.008)‡ (0.014) (0.028) (0.028)
SA −0:036 0.003 −0:033 0.013 −0:015 −0:003
(0.013)‡ (0.007) (0.011)‡ (0.019) (0.043) (0.043)
TAS 0.004 −0:005 −0:001 0.036 0.042 0.078
(0.009) (0.006) (0.008) (0.016)§ (0.034) (0.035)§
ACT −0:010 0.001 −0:009 0.028 −0:004 0.024
(0.013) (0.006) (0.011) (0.018) (0.046) (0.047)
NT −0:090 0.010 −0:080 0.002 −0:058 −0:056
(0.017)‡ (0.009) (0.016)‡ (0.031) (0.048) (0.046)
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Table 5 (continued )
Variable Pr(ymar =0,yspd =0,ycoc =0|x) Pr(yspd =0,ycoc =0|rmar =1,x)
Participation Misreporting Overall Participation Misreporting Overall
PRESENT 0.000 0.009 0.009 0.000 −0:055 −0:055
(0.000) (0.003)‡ (0.003)‡ (0.000) (0.014)‡ (0.014)‡
HELP 0.000 0.002 0.002 0.000 −0:017 −0:017
(0.000) (0.002) (0.002) (0.000) (0.015) (0.015)
SURVTYPE 0.000 0.010 0.010 0.000 −0:059 −0:059
(0.000) (0.004)‡ (0.004)‡ (0.000) (0.019)‡ (0.019)‡
TRUST 0.000 0.069 0.069 0.000 −0:409 −0:409
(0.000) (0.022)‡ (0.022)‡ (0.000) (0.119)‡ (0.119)‡
†Standard errors are given in parentheses. A positive marginal effect for participation represents an increase in
the probability of participation whereas a negative marginal effect for misreporting represents an increase in the
probability of misreporting.
‡Significant at the 1% level.
§Significant at the 5% level.
§§Significant at the 10% level.
estimate partial effects on all these different marginal, joint and conditional probabilities. For
brevity, we present partial effects for a joint and a conditional probability, which we discuss
briefly. Full results are available from the authors on request. In particular, Table 5 presents
partial effects on the probabilities of the two cases (estimated at sample means): the recorded
probability of zero consumption of all three drugs .Pr.ymar = 0, yspd = 0, ycoc = 0|x// and the
probability of reporting zero consumption of speed and cocaine, conditionally on predicted
participation in marijuana, i.e. Pr.yspd =0, ycoc =0|rmar =1,x/.
Consider first the zero reported consumption of all three drugs .Pr.ymar = 0, yspd = 0,
ycoc = 0|x//. It appears that being male is inversely associated with this probability, with the
non-participation and misreporting effects serving to operate in the same direction. For in-
stance, males are 5.3 percentage points (PPs) less likely to abstain from all three drugs and they
have a 0.6-PP lower chance of accurately reporting such zero consumption. This results in an
overall 5.9-PP lower probability of recording zero consumption for males compared with fe-
males. Some of the effects ofmain occupation and education are interesting with negative effects
on the probability of reporting non-participation across all three drugs with the misreporting
effects operating in the opposite direction, thereby serving to moderate the participation effects.
Turning to education, degree holders have a 1.8-PP lower chance of abstaining from all
three drugs but a 2-PP higher chance of accurately reporting such non-participation, resulting
in an overall 0.2-PP lower probability of recording joint zero consumption across all three
drugs relatively to those with less than year 12 qualifications. However, the overall effect is
statistically insignificant. In terms of the additional variables in the misreporting equation,
positive statistically significant partial effects are apparent for three of the four survey-related
variables, again highlighting the important role of survey conditions in the collection of accurate
(or otherwise) information.
The negative year effects indicate an increase in drug use over time. In contrast, we observe
a rise in accurate reporting of such non-participation across the years. We also observe some
significant state effects on the probability of zero consumption.
Next we look at the joint probability of observing a 0 for speed and cocaine, conditionally on
being amarijuana user .Pr.yspd =0, ycoc =0|rmar =1,x//. Bringing an analogy with the gateway
148 S. Brown, M. N. Harris, P. Srivastava and X. Zhang
effect where there is a progression from soft drugs to hard drugs, this probability allows us
to examine zero reporting (or non-participation) in the case of the harder drugs, cocaine and
speed, in a subpopulation of marijuana users. We find a significant association of factors such
as gender, presence of young children, employment and education with the non-participation
of speed and cocaine in the subpopulation of marijuana participants. For example males have
a 3-PP lower probability of non-participation in speed and cocaine than females, if they are
already marijuana users. Put differently, males are more likely to be hard-core drug users if they
are already marijuana users, which is consistent with a gateway effect for males.
5.3. Robustness checks, false positives results and validation exercises
The instruments that we use to identify the misreporting equation are all survey related, which
makes themunlikely tobe related todrugparticipation, providing a strong case for identification.
The importance of these factors in themisclassification literature and their statistical significance
in the estimated model lend further support to their inclusion in the misreporting equation.
Explicitly testing the validity of instruments in non-linear models is a difficult task (see, for
example, Davidson and MacKinnon (1993)) and there may also be concerns that some of the
instruments such as present and help are correlated with unobserved characteristics and are
therefore potentially endogenous. In light of this we therefore perform a series of robustness
checks to test whether our results change significantly with the inclusion and exclusion of the
respective identifying variables. Comparing across the resulting marginal effects, we find that
the results are generally robust to the various specifications for marijuana and speed although
we observe some differences for cocaine (which are presumably a result of the very low recorded
participation rate). Although for brevity we do not present the results from the various model
specifications, they are available from the authors on request. Instead, in Table 6 we provide a
comparison of the various specifications on the basis of the joint probability of participation
and accurate reporting which we contrast with the sample rate of drug participation. Consistent
with the results relating to the marginal effects, for marijuana and speed the joint probability of
participation and accurate reporting mimics the sample rate of participation quite well whereas
we see some differences for cocaine. Thus, in short, our findings do not appear to be heavily
reliant on the particular choice of identifying variable(s).
Although most of the reporting bias is believed to be in the direction of underreporting there
is also some evidence from the literature on overreporting. Such false positive rates are generally
lower than false negative ones (see, for example, Visher andMcFadden (1991) andHarrison and
Hughes (1997)). However, as a ‘litmus test’ to gauge the likely magnitudes of any false positive
results we conduct a simple test reversing the 1s to 0s and re-estimating the model. For all three
drugs the misreporting effects appear to be very small, ranging from 0.81% for cocaine to 4.67%
for marijuana. We also extended the basic framework to allow jointly for false positive and
false negative results. The estimated rates for the former were found to be even lower (at 0.04%,
0.02% and 0.06% respectively). Both of these exercises suggest that the levels of misreporting
with regard to false positive results are very low and therefore would not unduly affect the main
results that are reported in the paper.
We also restricted the sample to individuals who have reported having ever used the drug (the
National Drug Stategy Household Survey does not collect information on previous month’s
use): if themodel is well specifiedmisreporting rates should be significantly lower as stigma rates
will obviously be much reduced in this subsample. Indeed, we do find much less misreporting in
these subsamples (for example, the percentage difference bias between the observed proportions
of marijuana users, 0.122, and the predicted rate of users, 0.259, drops significantly from 113%
for the full sample to 55% for the subsample of those who have ever usedmarijuana). Again, this
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Table 6. Comparison across specifications†
Results Results for Results for Results for Results for Results for
for main specification specification specification specification specification
specification 1 2 3 4 5
Marijuana
Sample rate of participation 0.1215 0.1215 0.1215 0.1215 0.1215 0.1215
Joint probability of
participation and 0.1206 0.1079 0.1411 0.1431 0.1442 0.1506
accurate reporting, (0.0013)‡ (0.0077)‡ (0.0096)‡ (0.0062)‡ (0.0053)‡ (0.0097)‡
Pr.rmar =1,mmar =1|x/
Speed
Sample rate of participation 0.0316 0.0316 0.0316 0.0316 0.0316 0.0316
Joint probability of
participation and 0.0281 0.0386 0.0373 0.0383 0.0360 0.0352
accurate reporting, (0.0007)‡ (0.0011)‡ (0.0010)‡ (0.0008)‡ (0.0010)‡ (0.0019)‡
Pr.rspd =1,mspd =1|x/
Cocaine
Sample rate of participation 0.0127 0.0127 0.0127 0.0127 0.0127 0.0127
Joint probability of
participation and 0.0137 0.0028 0.0060 0.0031 0.0032 0.0097
accurate reporting, (0.0007)‡ (0.0010)‡ (0.0009)‡ (0.0010)‡ (0.0007)‡ (0.0006)‡
Pr.rcoc =1,mcoc =1|x/
†Standard errors are given in parentheses. The five specifications are similar to the main specification except for
the following details: specification 1, present only; specification 2, help only; specification 3, survey type only;
specification 4, trust only; specification 5, survey type and trust only.
‡Significant at the 1% level.
validation exercise gives us strong confidence inourmainfindings.Unfortunately the subsamples
of those who have ever used speed and cocaine are too small for robust analysis.
The final validation exercise that we conduct involves estimating the model on legal drugs
(alcohol and tobacco), which, unlike illegal drugs, do not pose any risk of legal prosecution and
are much less stigmatized given their general acceptability in the community. Thus, we would
expect less reporting bias in the case of legal drugs. On the basis of correlated IP models, we
still find strong effects of the identifying variables in the misreporting equations (the results
are available on request) and in Table 7 we present the recorded and predicted probabilities of
participation and the implied percentage biases. Clearly the reporting biases are much smaller
for alcohol (11%) and tobacco (63%) relative to the illegal drugs (where biases are 113%, 172%
Table 7. Comparison across legal and illegal drugs†
Results for Results for Results for Results for Results for
alcohol tobacco marijuana speed cocaine
Sample rate of participation 0.851 0.212 0.122 0.032 0.013
Predicted rate of participation, Pr.|r =1,x/ 0.947 0.345 0.259 0.086 0.045
% bias 11% 63% 113% 172% 257%
Probability of misreporting conditional on 0.101 0.257 0.357 0.154 0.643
participation, Pr.m=0|r =1,x/
†Probabilities are estimated from correlated IP models.
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and 257%, for marijuana, speed and cocaine respectively). Moreover, a priori we would expect
higher bias for tobacco relative to alcohol, due to the stronger adverse stigma that is associated
with the former. Table 7 also reports misreporting probabilities, conditionally on an individual
participating. Here we see that, for alcohol and tobacco, there is a 10% and 26% chance of
misreporting, compared with the much higher values that were found for the illegal drugs. So,
once more, this validation exercise gives us strong confidence in the model, the identifying
variables and the empirical findings.
5.4. Finite sample performance of the multivariate inverse probit model
Akey contribution of this paper is the use of amultivariatemodel which, as noted earlier, allows
us to estimate jointly drug participation and misreporting decisions across a range of drugs. A
parsimonious model of drug consumption such as a simple probit model that does not take
into account any misreporting will yield not only erroneous prediction of drug participation
rates but also biased parameter estimates. To highlight such differences, in Table A1 in the on-
line appendix we compare partial effects (on the marginal probability of drug participation)
of some selected covariates from the MIP model and simple probit models. Clearly, we see
some contrasting effects from the two models, with differences in magnitude and statistical
significance. In extreme cases such as tertiary degree and income, we have opposite effects
of covariates on drug participation. Thus, a simple probit model is likely to provide biased
parameter estimates and partial effects if misreporting is prevalent.
The MIP model is also preferred to the correlated IP model as it takes into account the likely
cross-drug correlations. If estimated in isolation where correlations across participation and
misreporting equations exist, but are ignored, estimated parameters and subsequent analysis
are potentially biased and/or inefficiently estimated since they are based on misspecified models
and/or models where not all relevant information is being utilized. For instance, from our
data, the observed sample proportion of individuals jointly consuming marijuana, speed and
cocaine is 0.64%. Using the MIP model we would predict this joint probability to be 0.614%
whereas the correlated IP model would estimate it at only 0.005%. Clearly the MIP model that
fully accounts for correlations within and across drugs exhibits better performance than the
correlated IP model.
Indeed, if simple univariate estimations of these models yielded essentially the same results
as the much more complex MIP approach, then researchers would surely prefer the former (al-
though somequantities of potential interestwouldbe lost, or not as easily obtained).Toascertain
the relative performance of a range of models that could have potentially been considered here
we conduct someMonte Carlo simulations. Tomake these findingsmore relevant to the applica-
tion at hand we simulate on the observed data and estimated parameters. Explicitly, we compare
the multivariate model performance with that of a univariate model, i.e. the correlated IPmodel
where the participation and misreporting equations are correlated for each drug but not across
the drugs. Additionally we also consider themodel that was suggested byHausman et al. (1998),
which provides a good basis for comparison; here the participation equation is specified as in the
correlated IP orMIPmodel but the misreporting probabilities are constants (and not a function
of covariates).We thus compare the (relative) performance of themodel ofHausman et al. (1998)
(for consistency, considered in a systems framework) with the correlated IP and MIP models.
For the data-generating process (DGP) we consider three scenarios:
(a) the true MIP model,
(b) three independent IPC models and
(c) the Hausman et al. (1998) form.
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With the last, the error terms in the participation and misreporting equations are allowed to
be correlated. Therefore, the MIP is a generalized model for both the correlated IP and the
Hausman et al. (1998)model, in terms of allowing decisions to be taken jointly andmisreporting
decisions to be influenced by covariates respectively. Finally, we consider an additional set
of experiments to determine whether the model is sensitive to the underlying assumptions of
normality.
5.4.1. Monte Carlo evidence
Asnoted,with suchahighly specifiedmodel, a comparisonof all estimated coefficientswouldnot
be particularly illuminating. Instead, in comparing across the various approaches we examine a
range of estimated summary probabilities as we envisage that these would be of primary interest
to policy makers. In each scenario, for a particular probability we present
(a) the true average probability over Q replications, P¯.·/,
(b) the estimated average probability over Q replications, ˆ¯P.·/, and
(c) the root-mean-square error of the estimated probability, RMSEP.·/.
To shed light on estimated parameters, we also report the averaged root-mean-square error over
all estimated parameters, AveRMSEpara.
As expected, for the (true) MIP model all estimated probabilities are very close to the cor-
responding true probabilities and with very low RMSEs. In fact, almost all RMSEs from the
MIP model are lower than those from the correlated IP and Hausman et al. (1998) models.
Although the correlated IP model performs well in estimating marginal probabilities of a single
drug consumption and probabilities of misreporting conditional on actual consumption in a
single drug, the estimated joint probabilities of consuming more than one type of drug appear
to be quite out. Ignoring the influence of individual characteristics on misreporting (i.e. the
model of Hausman et al. (1998)) appears generally to result in even greater discrepancies all
associated with high RMSEs. For details, refer to the results presented in Table A2 in the on-line
appendix. Although it might not be strictly valid to generalize these findings universally, they
suggest that, if cross-drug correlations do exist, finite sample biased quantities of interest might
result if ignored. And even more severe biases can arise if misreporting or misclassification
propensities are a function of covariates and these are ignored in estimations. The results on
averaged RMSEs over all estimated parameters reinforce the above results, i.e. the finite sample
estimation bias from the MIP model is essentially 0, with that from the correlated IP model
being significantly higher and that from the model of Hausman et al. (1998) higher still.
When the true DGP is an independent correlated IP model for each of the three drugs, we see
that again the estimated probabilities from theMIPmodel are very close to the true probabilities
and with low RMSEs. We also find that the MIP does an excellent job of estimating the true
non-zero correlations; and the average estimated correlation coefficients across drugs are all very
close to 0 (their true values) and with very low RMSEs. Moreover, the averaged RMSE over
all parameters is very small at 0.002. Detailed results can be found in Table A3 and Table A4 in
the on-line appendix. Thus, even if correlations do not exist across drugs but within, the MIP
is still a ‘safe option’ in correctly estimating all quantities of interest. When the true DGP is the
model of Hausman et al. (1998) (where an individual’s decision tomisreport is not influenced by
their characteristics but cross- andwithin-drug correlations exist), although being overspecified,
the MIP model performs exceptionally well in terms of estimating the probabilities that were
considered. For example, for Pr.mcoc =0|rcoc =1/, whereas the true probability is 94.15%, this
is estimated as (on average) 94.13% by the MIP model, with an RMSE of 0.0056. And once
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more, the averagedRMSEof all estimated parameters is extremely small (at 0.0016). All relevant
results are listed in Table A5 in the on-line appendix.
The assumption that the error terms in the multiple-equation system independently and iden-
tically follow a multivariate normal distribution could be considered relatively restrictive, but
this specification does allow us to estimate jointly participation and misreporting behaviours
across a range of drugs. Some previous studies have relaxed such distributional assumptions
(e.g. Chen et al. (2009) and Feng and Hu (2013)) but they have not considered misreporting
or misclassification on multiple events, i.e. not allowing for correlations across events. In our
application, we indeed find significant cross-drug correlations, which, if ignored in estimation,
can have adverse effects on the results (as demonstrated above). However, the assumption of
normality can be viewed as an identifying assumption; therefore finally we conduct some ex-
periments to ascertain how important this identifying assumption is. With the MIP model as
the true DGP, we now allow the multivariate error terms to have non-normal distributions:
following a mixture distribution of 0:95N.0,Σ6/ + 0:05N.0, I6/. The results demonstrate that
the MIP model estimations are again robust to this scenario (Table A6 in the on-line appendix).
We repeated this exercise assuming other forms of non-normality, such as othermixing distribu-
tions and multivariate t-distributions with very low degrees of freedom, and, again, the results
were essentially robust to such violations. These findings, overall, give us strong confidence in
our overall findings and approach.
6. Conclusions
In this paper we have explored the potential implications of misreporting in survey data in the
context of reporting consumption of three illicit drugs (marijuana, cocaine and speed). The
widespread use of data collected from individual and household level surveys by researchers
and policy makers is clearly reliant on respondents supplying accurate and reliable informa-
tion. Indeed, estimated participation rates of illegal drugs are invariably inferred from such
sample-based data. It is apparent, however, that in the context of gathering sensitive infor-
mation individuals may misreport their true situation, leading (here) to an excess amount of
0-observations in the context of questions relating to activities such as illicit drug consumption:
individuals are likely to deny their participation for a variety of reasons, such as fear of being
caught, stigma and moral concerns.
Overall, we find that misreporting has a significant effect on observed participation rates such
that, across all three drugs, the predicted marginal probabilities of participation are substan-
tially higher than indicated by the raw data. This is caused by some quite high propensities to
misreport. Interestingly, our findings suggest that the extent of misreporting is influenced by
how the survey was administered and how much trust participants placed on the survey, as
well as factors such as the presence of other individuals when the survey was completed. We
conclude that the conditions under which survey data are collected influence the accuracy of the
information that is obtained. Our findings suggest that accounting formisreporting is important
in the context of using survey data related to sensitive activities, especially where such data are
used to inform public policy.
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